Tecnau offers a complete product portfolio dedicated to paper handling, monitoring, processing and finishing for the digital printing industry. We are devoted to providing integrated solutions to support the broadest array of applications for Transactional Printing, TransPromo, Direct Mail, Publishing, Graphic Arts, Book on Demand and Short Run. Global service and around-the-clock support help ensure our reputation as the industry’s reliability leader. Our products increase productivity, cut labor and paper costs, and even make new applications possible – Tecnau solutions truly empower digital print to help you do more with less.
Technomad Inc.
Technomad manufactures professional grade outdoor audio equipment, including loudspeakers, power amplifiers, and portable audio systems. For applications ranging from background sound to stadium audio, Technomad has a solution which will provide the highest quality performance coupled with unmatched outdoor durability. All products are made in the US with a carbon zero production process for the cabinets, the greenest loudspeakers available. We also have a kickass audio player/recorder, the Schedulon. Playback can easily be configured using a web UI and schedule parameters include time, date, day of the week and NEW sunset and sunrise based on GPS location. Also new for the Schedulon is the option of contact closure control. Eight contacts can be configured as input or output triggers. Highly configurable, extremely reliable and best of all, easy to use – check out the Schedulon for your automated playback requirements.
Technology Container Corp.
REUSABLE SUSTAINABLE DISTRIBUTION BOXES
Tea Forte
Extraordinary teas meet unparalleled presentation for an exceptional experience that could only be Tea Forté. Our diverse, subtle flavors are a result of creating without compromise. Handcrafted luxury tea blends, design-driven accessories and exquisite packaging come together for an experience worth savoring every day. Your source for exclusive tea products to enjoy and share. Tea Forté makes gifting easy with an array of beautiful tea gifts at a variety of price points that are perfect for any occasion. Steeped in over 35 countries, Tea Forté is proudly featured at leading | Tea Forte: Known for its signature tea infuser, an impressive tea service is an experience guests remember. Our modern take on teas comes in the form of our elegant pyramid infuser: a unique shape and style, designed not only to let the flavors of the tea shine, but also to delight all the senses at once. Unparalleled quality and presentation are what make a truly unforgettable experience. The perfect end to an exquisite meal. A curated assortment of teas to complete the in-room service experience. A soothing herbal infusion to top off a spa treatment. Creating the kind of experience your guests will remember means delighting and inspiring them at every turn. Served at leading hotels, restaurant, spas, resorts, cruise ships and retailers in over 35 countries, Tea Forté provides the world’s most discerning guests an exceptional tea experience. Let us customize a tea experience that caters to your clientele with Tea Forté’s signature pyramid, innovative tea blends, and design-driven accessories.
Targetmol Chemicals Inc.
TargetMol is the global supplier of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies, and novel life-science kits for laboratory and scientific use.
Takeda Pharmaceuticals
Creating better health for people and a brighter future for the world is our purpose. The science and technology we advance are constantly evolving. But through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people. | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com. | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. www.takeda.com
Takeda Pharmaceuticals U.S.A., Inc.
As one of the world’s leading biopharmaceutical companies, Takeda is committed to bringing Better Health and a Brighter future to people worldwide. We aspire to bring our leadership in translating science into life-changing medicines to the next level, in our core focus areas; oncology, gastroenterology, neuroscience, rare diseases, plasma-derived therapies, and vaccines.
Takeda Pharmaceuticals USA Inc.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com.
Takeda
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology extends more than 25 years and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care. We are building on our portfolio of approved medicines for hematologic cancers and solid tumors and advancing a cutting-edge pipeline focused on the power of innate immunity. We aim to introduce new classes of immunotherapies that can lead to deep, durable responses so that more patients can benefit from – and have access to – innovative medicines. | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. www.takeda.com | Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. | Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. www.takeda.com